4//SEC Filing
Howe Jill Ann 4
Accession 0000950170-25-038116
CIK 0000876343other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:30 PM ET
Size
5.4 KB
Accession
0000950170-25-038116
Insider Transaction Report
Form 4
Howe Jill Ann
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-03-10+750,000→ 750,000 totalExercise: $0.53Exp: 2035-03-10→ Common Shares (750,000 underlying)
Footnotes (1)
- [F1]One quarter of the options shall vest on March 10, 2026, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001892397
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:30 PM ET
- Size
- 5.4 KB